Product Code: 5357
The global serrata extract market is anticipated to expand significantly through 2030, on account of product usage in herbal medicines and government support for its cultivation. The serrata extract is widely utilized in ayurvedic herbal formulations for treating numerous ailments including osteoarthritis, asthma, inflammatory bowel conditions, and as anti-cancer drug.
Furthermore, investments by leading manufacturers in R&D for the product, in consort with increased government assistance are projected to boost market expansion. For example, the Indian government keeps track of the critical natural resource - Boswellia Serrata, through its Forestry Service. They conduct field inventories on a regular basis to measure plant numbers, train field associates, and determine pricing in order to assure the abundance of Boswellia forests spread over the country's sixteen states.
The serrata extract is available in two forms, i.e., liquid and powder. The liquid serrata extract market share is predicted to grow with strong CAGR during the forecast period, due to rising use of the product as an ingredient in essential oils for aromatherapy and production of perfumes. Widespread popularity of aromatherapy, in tandem with consumer preference for smelling nice are fostering the demand for serrata extract.
Moving on, the numerous applications of serrata extract include herbal medicine, dietary supplements, and aromatherapy. The other application of the product is in the pharmaceutical industry and is slated to generate moderate revenues for the market in the coming years. The Boswellic acid present in serrata extract is widely used in medicine due to its potential to decrease inflammation, regulate immunological function, combat cancer, and cure chronic diseases including asthma and arthritis.
For example, in December 2021, Hyderabad-based Lee Health Domain launched an oral tablet Actokin, a nutraceutical containing collagen, curcumin complex, and Boswellia serrata extract. The tablet is to be used as an adjuvant therapy to treat joint problems, exhaustion, and neuropathic pain connected with post-viral infections such as coronavirus. It may also be used in place of pain killers without any adverse effects.
Regionally, the Europe is likely to emerge as a lucrative destination for the manufacturers and enterprises in the Serrata extract market in the coming years, owing to the growing number of health-conscious consumers in the region. Due to the increasing awareness of health benefits of serrata extract, the Europe market is expected to record a CAGR of 10.5% to be valued over USD 64.5s million by 2030.
Speaking of the competitive landscape, the participants are putting efforts to enhance their present medical technology, consequently improving the overall market scenario for the next years. Citing an instance, in April 2021, Cosmax Bio Inc., a South Korean manufacturer of dietary supplement, has produced a novel ingredient based on Hydrangea serrata leaf extract that is claimed to improve skin health and help weight management. It is a 100% plant-derived ingestible beauty product that meets the demands of customers, particularly during the COVID-19 era.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Methodology
- 1.2 Base estimation & working
- 1.2.1 North America
- 1.2.2 Europe
- 1.2.3 Asia Pacific
- 1.2.4 Latin America
- 1.2.5 Middle East & Africa
- 1.3 Forecast calculation
- 1.3.1 COVID-19 impact calculations on industry forecast
- 1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
- 1.4.2.1 Paid sources
- 1.4.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Serrata extract market 360 degree synopsis, 2018 - 2030
- 2.1.1 Business trends
- 2.1.2 Form trends
- 2.1.3 Application trends
- 2.1.4 Regional trends
Chapter 3 Serrata Extract Industry Insights
- 3.1 Industry segmentation
- 3.2 COVID-19 impact on industry landscape
- 3.3 Industry ecosystem analysis
- 3.3.1 Profit margin analysis
- 3.3.2 Value addition at each stage
- 3.3.3 Distribution channel analysis
- 3.3.4 Vendor matrix
- 3.4 Industry megatrends
- 3.5 Innovation & sustainability
- 3.6 Industry impact forces
- 3.6.1 Growth drivers
- 3.6.2 Industry pitfalls & challenges
- 3.7 Regulatory landscape
- 3.7.1 North America
- 3.7.2 Europe
- 3.7.3 Asia Pacific
- 3.8 Growth potential analysis
- 3.9 Competitive landscape, 2021
- 3.9.1 Top players overview, 2021
- 3.9.2 Strategy dashboard
- 3.10 Porter's analysis
- 3.10.1 Supplier power
- 3.10.2 Buyer power
- 3.10.3 Threat of new entrants
- 3.10.4 Threat of substitutes
- 3.10.5 Industry rivalry
- 3.11 Price trends
- 3.11.1 Regional price trends
- 3.11.2 Cost structure analysis
- 3.11.2.1 R&D cost
- 3.11.2.2 Manufacturing & equipment cost
- 3.11.2.3 Raw confectionery cost
- 3.11.2.4 Distribution cots
- 3.11.2.5 Operating cost
- 3.11.2.6 Miscellaneous cost
- 3.12 PESTEL analysis
- 3.13 Impact of COVID-19 on food sector
Chapter 4 Serrata extract market, By Form
- 4.1 Global serrata extract market confectionery insights
- 4.2 Powder
- 4.2.1 Market estimates and forecast, 2018 - 2030
- 4.2.2 Market estimates and forecast, by region, 2018 - 2030
- 4.3 Liquid
- 4.3.1 Market estimates and forecast, 2018 - 2030
- 4.3.2 Market estimates and forecast, by region, 2018 - 2030
Chapter 5 Serrata extract market, By Application
- 5.1 Global serrata extract market application insights
- 5.2 Herbal medicine
- 5.2.1 Market estimates and forecast, 2018 - 2030
- 5.2.2 Market estimates and forecast, by region, 2018 - 2030
- 5.3 Food supplements
- 5.3.1 Market estimates and forecast, 2018 - 2030
- 5.3.2 Market estimates and forecast, by region, 2018 - 2030
- 5.4 Aromatherapy
- 5.4.1 Market estimates and forecast, 2018 - 2030
- 5.4.2 Market estimates and forecast, by region, 2018 - 2030
- 5.5 Others
- 5.5.1 Market estimates and forecast, 2018 - 2030
- 5.5.2 Market estimates and forecast, by region, 2018 - 2030
Chapter 6 Serrata extract market, By Region
- 6.1 Global serrata extract market regional insights
- 6.2 North America
- 6.2.1 Market estimates and forecast, 2018 - 2030
- 6.2.2 Market estimates and forecast, by form, 2018 - 2030
- 6.2.3 Market estimates and forecast, by application, 2018 - 2030
- 6.2.4 U.S.
- 6.2.4.1 Market estimates and forecast, 2018 - 2030
- 6.2.4.2 Market estimates and forecast, by form, 2018 - 2030
- 6.2.4.3 Market estimates and forecast, by application, 2018 - 2030
- 6.2.5 Canada
- 6.2.5.1 Market estimates and forecast, 2018 - 2030
- 6.2.5.2 Market estimates and forecast, by form, 2018 - 2030
- 6.2.5.3 Market estimates and forecast, by application, 2018 - 2030
- 6.3 Europe
- 6.3.1 Market estimates and forecast, 2018 - 2030
- 6.3.2 Market estimates and forecast, by form, 2018 - 2030
- 6.3.3 Market estimates and forecast, by application, 2018 - 2030
- 6.3.4 Germany
- 6.3.4.1 Market estimates and forecast, 2018 - 2030
- 6.3.4.2 Market estimates and forecast, by form, 2018 - 2030
- 6.3.4.3 Market estimates and forecast, by application, 2018 - 2030
- 6.3.5 UK
- 6.3.5.1 Market estimates and forecast, 2018 - 2030
- 6.3.5.2 Market estimates and forecast, by form, 2018 - 2030
- 6.3.5.3 Market estimates and forecast, by application, 2018 - 2030
- 6.3.6 France
- 6.3.6.1 Market estimates and forecast, 2018 - 2030
- 6.3.6.2 Market estimates and forecast, by form, 2018 - 2030
- 6.3.6.3 Market estimates and forecast, by application, 2018 - 2030
- 6.3.7 Italy
- 6.3.7.1 Market estimates and forecast, 2018 - 2030
- 6.3.7.2 Market estimates and forecast, by form, 2018 - 2030
- 6.3.7.3 Market estimates and forecast, by application, 2018 - 2030
- 6.3.8 Spain
- 6.3.8.1 Market estimates and forecast, 2018 - 2030
- 6.3.8.2 Market estimates and forecast, by form, 2018 - 2030
- 6.3.8.3 Market estimates and forecast, by application, 2018 - 2030
- 6.4 Asia Pacific
- 6.4.1 Market estimates and forecast, 2018 - 2030
- 6.4.2 Market estimates and forecast, by form, 2018 - 2030
- 6.4.3 Market estimates and forecast, by application, 2018 - 2030
- 6.4.4 China
- 6.4.4.1 Market estimates and forecast, 2018 - 2030
- 6.4.4.2 Market estimates and forecast, by form, 2018 - 2030
- 6.4.4.3 Market estimates and forecast, by application, 2018 - 2030
- 6.4.5 India
- 6.4.5.1 Market estimates and forecast, 2018 - 2030
- 6.4.5.2 Market estimates and forecast, by form, 2018 - 2030
- 6.4.5.3 Market estimates and forecast, by application, 2018 - 2030
- 6.4.6 Japan
- 6.4.6.1 Market estimates and forecast, 2018 - 2030
- 6.4.6.2 Market estimates and forecast, by form, 2018 - 2030
- 6.4.6.3 Market estimates and forecast, by application, 2018 - 2030
- 6.5 Latin America
- 6.5.1 Market estimates and forecast, 2018 - 2030
- 6.5.2 Market estimates and forecast, by form, 2018 - 2030
- 6.5.3 Market estimates and forecast, by application, 2018 - 2030
- 6.5.4 Brazil
- 6.5.4.1 Market estimates and forecast, 2018 - 2030
- 6.5.4.2 Market estimates and forecast, by form, 2018 - 2030
- 6.5.4.3 Market estimates and forecast, by application, 2018 - 2030
- 6.5.5 Mexico
- 6.5.5.1 Market estimates and forecast, 2018 - 2030
- 6.5.5.2 Market estimates and forecast, by form, 2018 - 2030
- 6.5.5.3 Market estimates and forecast, by application, 2018 - 2030
- 6.6 Middle East & Africa (MEA)
- 6.6.1 Market estimates and forecast, 2018 - 2030
- 6.6.2 Market estimates and forecast, by form, 2018 - 2030
- 6.6.3 Market estimates and forecast, by application, 2018 - 2030
- 6.6.4 South Africa
- 6.6.4.1 Market estimates and forecast, 2018 - 2030
- 6.6.4.2 Market estimates and forecast, by form, 2018 - 2030
- 6.6.4.3 Market estimates and forecast, by application, 2018 - 2030
- 6.6.5 GCC
- 6.6.5.1 Market estimates and forecast, 2018 - 2030
- 6.6.5.2 Market estimates and forecast, by form, 2018 - 2030
- 6.6.5.3 Market estimates and forecast, by application, 2018 - 2030
Chapter 7 Company Profiles
- 7.1 Manus Aktteva biopharma LLP
- 7.1.1 Business overview
- 7.1.2 Financial data
- 7.1.3 Product landscape
- 7.1.4 Strategic outlook
- 7.1.5 SWOT analysis
- 7.2 Marven Bio Chem
- 7.2.1 Business overview
- 7.2.2 Financial data
- 7.2.3 Product landscape
- 7.2.4 Strategic outlook
- 7.2.5 SWOT analysis
- 7.3 Hernal BioActives LLP
- 7.3.1 Business overview
- 7.3.2 Financial data
- 7.3.3 Product landscape
- 7.3.4 Strategic outlook
- 7.3.5 SWOT analysis
- 7.4 Sanat, S.A
- 7.4.1 Business overview
- 7.4.2 Financial data
- 7.4.3 Product landscape
- 7.4.4 Strategic outlook
- 7.4.5 SWOT analysis
- 7.5 Jayshree Nath Herbals
- 7.5.1 Business overview
- 7.5.2 Financial data
- 7.5.3 Product landscape
- 7.5.4 Strategic outlook
- 7.5.5 SWOT analysis
- 7.6 Herbal Creations
- 7.6.1 Business overview
- 7.6.2 Financial data
- 7.6.3 Product landscape
- 7.6.4 Strategic outlook
- 7.6.5 SWOT analysis
- 7.7 Ambe NS Agro product pvt ltd.
- 7.7.1 Business overview
- 7.7.2 Financial data
- 7.7.3 Product landscape
- 7.7.4 Strategic outlook
- 7.7.5 SWOT analysis
- 7.8 Venkatesh Natural Extract pvt ltd.
- 7.8.1 Business overview
- 7.8.2 Financial data
- 7.8.3 Product landscape
- 7.8.4 Strategic outlook
- 7.8.5 SWOT analysis
- 7.9 Himalayan Herbaria
- 7.9.1 Business overview
- 7.9.2 Financial data
- 7.9.3 Product landscape
- 7.9.4 Strategic outlook
- 7.9.5 SWOT analysis
- 7.10 Alchem International
- 7.10.1 Business overview
- 7.10.2 Financial data
- 7.10.3 Product landscape
- 7.10.4 Strategic outlook
- 7.10.5 SWOT analysis